Oncolytics Biotech (ONCY) Return on Assets (2009 - 2026)
Oncolytics Biotech (ONCY) posted quarterly Return on Assets of 0.02% for Q4 2025, down 1.0% year-over-year from 0.02% in Q4 2024, and little changed quarter-over-quarter from 0.02% in Q3 2025.
Oncolytics Biotech (ONCY) Return on Assets (2009 - 2026) Analysis & Trends
Oncolytics Biotech (ONCY) has reported Return on Assets for 17 consecutive years, with 0.02% the latest figure, recorded in Q4 2025.
- In Q4 2025, Return on Assets fell 1.0% year-over-year to 0.02%; the TTM figure through Dec 2025 stood at 0.02% (down 1.0% YoY), while the FY2025 annual figure was 0.03%, down 2.0% from the prior year.
- Return on Assets held at 0.02% in Q4 2025 per ONCY's latest filing, from 0.02% in the prior quarter.
- Across five years, Return on Assets topped out at 0.01% in Q3 2021 and bottomed at 0.02% in Q3 2024.
- Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2022.
- Annual changes were most pronounced in 2021 — Return on Assets rose 1 bps — and 2022, when it declined 2 bps.
- Oncolytics Biotech's Return on Assets stood at 0.01% in 2021, then tumbled by 39 bps to 0.01% in 2022, then sank by 33 bps to 0.01% in 2023, then climbed by 24 bps to 0.01% in 2024, then plunged by 52 bps to 0.02% in 2025.
- Business Quant data shows ONCY's Return on Assets at 0.02% in Q4 2025, 0.02% in Q3 2025, and 0.01% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.01 Bn | 132.16 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.18 Bn | 55.04 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.55 Bn | 28.24 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.19 Bn | 26.36 Bn | - | 0.00% |
| 10 | Oncolytics Biotech | 97.90 Mn | 97.90 Mn | - | -0.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.03% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.01% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | 0.01% |
| Jun 30, 2021 | 0.01% |